Another blow to Merck: Their potential blockbuster diabetes drug is showing some cardiac side effects. “”I expected the advisory panel to turn the drug down. When they didn’t, I was really surprised. And so I now had a potential public health catastrophe in the waiting.”
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
